145 results match your criteria: "and Dartmouth-Hitchcock Medical Center[Affiliation]"
Br J Clin Pharmacol
July 2024
Section of Clinical Pharmacology, Department of Medicine, The Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Aims: This manuscript is a description of the clinical pharmacology and therapeutics (CPT) course that is required to be taken, and passed, by all medical students at the Geisel School of Medicine at Dartmouth during their final year of training, prior to entering their internship/residency.
Methods: We present a detailed CPT course curriculum, which includes the novel use of simulated expected professional activities (EPAs) and an analysis of the level of confidence the students who took the course had at the beginning and at the end of the course in performing the three simulated EPAs.
Results: The course currently consists of 31 h of presentations on what are considered major clinical pharmacology topics and is led by two clinical pharmacologists at Dartmouth (D.
Paediatr Anaesth
September 2024
Department of Anesthesiology, Geisel School of Medicine and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Background: A lack of anesthesia and surgical capacity leaves approximately 1.7 billion children per annum without access to surgical and anesthetic care.
Review: Over the past 50 years, the predominant strategy to address this lack of access has been to provide surgical capacity primarily from high-income countries (HICs) to low and middle-income countries (LMICs) in the form of short-term surgical missions.
Endoscopy
October 2024
Material Analysis Laboratory, INSA Lyon, Villeurbanne, France.
Introduction: The environmental impact of endoscopy, including small-bowel capsule endoscopy (SBCE), is a topic of growing attention and concern. This study aimed to evaluate the greenhouse gas (GHG) emissions (kgCO) generated by an SBCE procedure.
Methods: Life cycle assessment methodology (ISO 14040) was used to evaluate three brands of SBCE device and included emissions generated by patient travel, bowel preparation, capsule examination, and video recording.
J Educ Eval Health Prof
February 2024
Department of Pediatrics, The Warren Alpert Medical School of Brown University and Hasbro Children's Hospital, Providence, RI, USA.
Purpose: Despite educational mandates to assess resident teaching competence, limited instruments with validity evidence exist for this purpose. Existing instruments do not allow faculty to assess resident-led teaching in a large group format or whether teaching was interactive. This study gathers validity evidence on the use of the Resident-led Large Group Teaching Assessment Instrument (Relate), an instrument used by faculty to assess resident teaching competency.
View Article and Find Full Text PDFAnn Allergy Asthma Immunol
March 2024
Departments of Medicine and Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Canada; Evidence in Allergy Group, McMaster University and The Research Institute of St. Joe's Hamilton, Hamilton, Canada.
Sleep Health
December 2023
Department of Health and Community Systems, School of Nursing, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Veteran Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
Introduction: In adults at risk for obstructive sleep apnea, it is unclear what patient-level factors and symptoms may influence communication with healthcare providers regarding sleep difficulties. This analysis examined associations between sociodemographic characteristics, comorbidities, and obstructive sleep apnea-related symptoms and whether adults at high risk for obstructive sleep apnea reported trouble sleeping to an healthcare provider.
Methods: The sample included participants from the 2015-2018 National Health and Nutrition Examination Survey determined by a modified STOP-Bang to be at high risk for obstructive sleep apnea (n = 2009).
J Occup Environ Med
December 2023
From the Mathematica, Washington, DC (K.P.); Dartmouth Institute for Health Policy and Clinical Practice, Hanover, New Hampshire (K.P.); Vermont RETAIN Montpelier, VT (D.K., M.H.B., M.G., D.D., C.M.D., K.H.); Northeastern Vermont Regional Hospital, St Johnsbury, Vermont (D.D.); University of Pittsburgh School of Rehabilitation Sciences and School of Medicine, Pittsburgh, Pennsylvania (C.M.D.); University of Texas at Austin Value Institute for Health and Care, Austin, Texas (C.U., S.W.); and Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire (K.H.).
Purpose: Vermont has high rates of young people receiving federal disability benefits leading to substantial gaps in the workforce. The purpose of this project was to determine the unmet needs of interested parties in the workers' compensation (WC) process.
Methods: A type of focus group, experience groups, was used to elicit key parties' experiences in the WC system.
Purpose Of Review: Cognitive dysfunction is a complex condition that is becoming increasingly more prevalent. There has been growing acknowledgement that individuals with atrial fibrillation are at an increased risk of cognitive dysfunction beyond the association of age with both disorders. The purpose of this review is to explore the potential underlying mechanisms connecting atrial fibrillation and cognitive dysfunction and to examine the existing evidence for potential treatment options.
View Article and Find Full Text PDFInt J Mol Sci
July 2023
Department of Neurology, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA.
Multiple sclerosis (MS) is a clinically heterogenous disease. Currently, we cannot identify patients with more active disease who may potentially benefit from earlier interventions. Previous data from our lab identified the CXCL13 index (I), a measure of intrathecal production of CXCL13, as a potential biomarker to predict future disease activity in MS patients two years after diagnosis.
View Article and Find Full Text PDFNeurology
July 2023
From the Geisel School of Medicine at Dartmouth (N.M.R.), Hanover; and Dartmouth-Hitchcock Medical Center (N.M.R.), Lebanon, NH.
Cancer Chemother Pharmacol
September 2023
Clinical Pharmacology and Quantitative Pharmacology, R&D Clinical Pharmacology and Safety Sciences, AstraZeneca, Waltham, MA, USA.
Purpose: Adavosertib may alter exposure to substrates of the cytochrome P450 (CYP) family of enzymes. This study assessed its effect on the pharmacokinetics of a cocktail of probe substrates for CYP3A (midazolam), CYP2C19 (omeprazole), and CYP1A2 (caffeine).
Methods: Period 1: patients with locally advanced or metastatic solid tumors received 'cocktail': caffeine 200 mg, omeprazole 20 mg, and midazolam 2 mg (single dose); period 2: after 7- to 14-day washout, patients received adavosertib 225 mg twice daily on days 1-3 (five doses), with cocktail on day 3.
Cancer Chemother Pharmacol
August 2023
Clinical Pharmacology and Quantitative Pharmacology, R&D Clinical Pharmacology and Safety Sciences Clinical Pharmacology, Waltham, MA, USA.
J Nurs Adm
June 2023
Author Affiliations: Postdoctoral Research Fellow (Dr Godzik), Dartmouth College and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Research Fellow (Dr Godzik), Senior Research Scholar (Dr Hurley), and Director of Research (Dr Brennan), Care Dimensions, Danvers, Massachusetts; Professor in Gerontological Nursing (Dr Buck), University of Iowa, Iowa City; and Graduate Student (Dr Yacinthus), Regis College, Weston, Massachusetts.
Objective: This evaluation project focused on assessing the content validity of an adapted version of the Casey-Fink (CF) Graduate Nurse Experience Survey, which is aimed at measuring role transitions in nursing.
Background: Registered nurses in the hospice and palliative care field need training and confidence to be proficient in core skills including communication, interprofessional competence, and clinical skills required to care for the dying patient. However, a review of the literature revealed a gap in the availability of survey instruments to measure the confidence of nurses entering the field of hospice and palliative care.
World Allergy Organ J
March 2023
Translational Research in Paediatric Specialities Area, Division of Allergy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Mayo Clin Proc Innov Qual Outcomes
February 2023
Harvard Medical School and Massachusetts General Hospital, Boston, MA.
Given the significant advance of virtual care in the past year and half, it seems timely to focus on quality frameworks and how they have evolved collaboratively across health care organizations. Massachusetts General Hospital's (MGH) Center for TeleHealth and Mass General Brigham's (MGB) Virtual Care Program are committed to hosting annual symposia on key topics related to virtual care. Subject matter experts across the country, health care organizations, and academic medical centers are invited to participate.
View Article and Find Full Text PDFCancers (Basel)
December 2022
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.
The tumor microenvironment (TME) within and around a tumor is a complex interacting mixture of tumor cells with various stromal cells, including endothelial cells, fibroblasts, and immune cells. In the early steps of tumor formation, the local microenvironment tends to oppose carcinogenesis, while with cancer progression, the microenvironment skews into a protumoral TME and the tumor influences stromal cells to provide tumor-supporting functions. The creation and development of cancer are dependent on escape from immune recognition predominantly by influencing stromal cells, particularly immune cells, to suppress antitumor immunity.
View Article and Find Full Text PDFJ Appl Lab Med
March 2023
Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Background: In the US adverse drug reactions (ADRs) are estimated to cause 100 000 fatalities and cost over $136 billion annually. A patient's genes play a significant role in their response to a drug. Pharmacogenomics aims to optimize drug choice and dose for individual patients by characterizing patients' pharmacologically relevant genes to identify variants of known impact.
View Article and Find Full Text PDFJ Pediatr Health Care
March 2023
Mary Kay Jankowski, Associate Professor, Department of Psychiatry, Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Introduction: We examined changes in family engagement before versus during the pandemic in pediatric and family services and perceived facilitators and barriers to family engagement.
Method: We employed a mixed-methods assessment of staff and caregiver perspectives related to pediatric and family medicine clinics and family resource centers in rural northern New England. We used narrative synthesis to analyze qualitative interviews (n = 29) and descriptive statistics for quantitative surveys (n = 108).
J Allergy Clin Immunol
February 2023
Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
These evidence-based guidelines support patients, clinicians, and other stakeholders in decisions about the use of intranasal corticosteroids (INCS), biologics, and aspirin therapy after desensitization (ATAD) for the management of chronic rhinosinusitis with nasal polyposis (CRSwNP). It is important to note that the current evidence on surgery for CRSwNP was not assessed for this guideline nor were management options other than INCS, biologics, and ATAD. The Allergy-Immunology Joint Task Force on Practice Parameters formed a multidisciplinary guideline panel balanced to include the views of multiple stakeholders and to minimize potential biases.
View Article and Find Full Text PDFVaccines (Basel)
August 2022
Virology Laboratory, Department of Cell & Systems Biology, University of Toronto, Toronto, ON M5S 3B2, Canada.
Breast cancer treatment using plant-virus-based nanoparticles (PVNPs) has achieved considerable success in preclinical studies. PVNP-based breast cancer therapies include non-targeted and targeted nanoplatforms for delivery of anticancer therapeutic chemo and immune agents and cancer vaccines for activation of local and systemic antitumor immunity. Interestingly, PVNP platforms combined with other tumor immunotherapeutic options and other modalities of oncotherapy can improve tumor efficacy treatment.
View Article and Find Full Text PDFBiomedicines
August 2022
Department of Neurology, Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.
Multiple sclerosis (MS) is a highly heterogeneous disease involving a combination of inflammation, demyelination, and CNS injury. It is the leading cause of non-traumatic neurological disability in younger people. There is no cure, but treatments in the form of immunomodulatory drugs (IMDs) are available.
View Article and Find Full Text PDFInt J Tuberc Lung Dis
August 2022
Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Dartmouth, NH.
Ann Allergy Asthma Immunol
August 2022
Dartmouth Geisel School of Medicine and Dartmouth Hitchcock Medical Center, Section of Allergy, Lebanon, New Hampshire.
J Cancer Immunol (Wilmington)
January 2022
Department of Microbiology and Immunology, Dartmouth Geisel School of Medicine, Hanover, NH, United States.
Cancer immunotherapies using plant virus nanoparticles (PVNPs) have achieved considerable success in preclinical studies. PVNP based nanoplatforms can be endogenous immune adjuvants and act as nanocarriers that stabilize and deliver cancer antigens and exogenous immune adjuvants. Although they do not infect mammalian cells, PVNPs are viruses and they are variably recognized by pathogen pattern recognition receptors (PRR), activate innate immune cells including antigen-presenting cells (APCs), and increase the expression of costimulatory molecules.
View Article and Find Full Text PDF